Sandra Celina Fernandes Fonseca | Cardiology | Innovative Research Award

Innovative Research Award

Sandra Celina Fernandes Fonseca
University of Trás-os-Montes and Alto Douro
Sandra Celina Fernandes Fonseca
Affiliation University of Trás-os-Montes and Alto Douro
Country Portugal
Scopus ID 57191525441
Documents 23
Citations 85
h-index 5
Subject Area Cardiology
Event International Research Awards on Cardiology & Cardiovascular Medicine
ORCID 0000-0001-9468-7269

The Innovative Research Award recognizes sustained scholarly contributions that advance evidence-based understanding in cardiovascular and health sciences. Sandra Celina Fernandes Fonseca, affiliated with the University of Trás-os-Montes and Alto Douro, has developed an interdisciplinary research portfolio examining exercise physiology, cardiovascular responses, athlete well-being, and health promotion across diverse populations. Her publication record demonstrates engagement with clinically relevant topics at the intersection of cardiology, physical activity, and preventive medicine.[1]

Abstract

Fonseca’s research addresses the physiological and behavioral determinants of cardiovascular health, with particular emphasis on exercise responses, athlete health, and lifestyle-related risk factors. Her work integrates observational and applied methodologies to evaluate how physical activity, motivation, sleep, and substance use influence cardiovascular outcomes and performance indicators.[2]

Keywords

Cardiology; exercise physiology; cardiovascular medicine; athlete health; physical activity; preventive health; sleep quality; sports science.

Introduction

Contemporary cardiovascular research increasingly recognizes the importance of behavioral and environmental determinants of health. Fonseca’s investigations contribute to this perspective by examining how exercise intensity, perceived exertion, nutrition, and psychosocial variables affect cardiovascular adaptation and well-being across athletic and general populations.[3]

Research Profile

According to indexed author records, Fonseca has authored or co-authored 23 Scopus-indexed documents with 85 citations and an h-index of 5. Her scholarship spans cardiology, sports medicine, public health, and kinesiology, reflecting a multidisciplinary approach to cardiovascular prevention and health promotion.[1]

Research Contributions

  • Assessment of cardiovascular responses to exercise under varying behavioral conditions, including alcohol consumption.
  • Investigation of sleep quality, motivation, and mental health among Paralympic athletes.
  • Evaluation of caffeine-related effects on glycaemia and blood pressure in combat sports participants.
  • Analysis of physical activity patterns and self-rated health during the COVID-19 pandemic.

Publications

Selected publications include studies in Nutrients, Sports, Turkish Journal of Kinesiology, and O Mundo da Saúde. Notable recent works examine cardiovascular responses to exercise and alcohol interaction and predictive factors associated with athlete mental health during social isolation.[4]

Research Impact

The practical implications of Fonseca’s work extend to exercise prescription, athlete monitoring, and preventive cardiovascular care. By integrating physiological measures with behavioral indicators, her studies support more comprehensive approaches to health promotion and performance optimization.[5]

Award Suitability

Fonseca’s multidisciplinary output aligns with the objectives of the International Research Awards on Cardiology & Cardiovascular Medicine. Her emphasis on translational research, preventive health strategies, and evidence-informed interventions demonstrates relevance to current priorities in cardiovascular science and population health.[6]

Conclusion

Sandra Celina Fernandes Fonseca has established a coherent research agenda centered on exercise-related cardiovascular outcomes and health behavior. Her scholarly contributions provide meaningful insights for clinicians, researchers, and public health practitioners seeking to improve cardiovascular well-being through lifestyle-based interventions.

References

  1. Elsevier. (n.d.). Scopus author details: Sandra Celina Fernandes Fonseca, Author ID 57191525441. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57191525441
  2. Fonseca, S. C. F., et al. (2026). Cardiovascular Response to Exercise with and Without Alcohol Consumption. Nutrients.
    DOI: https://doi.org/10.3390/nu18091407
  3. Fonseca, S. C. F., et al. (2026). Predictive Factors of Mental Health in Athletes from the Paralympic Preparation Program During Social Isolation. Sports.
    DOI: https://doi.org/10.3390/sports14040160
  4. Fonseca, S. C. F., et al. (2025). Effects of caffeine on glycaemia and blood pressure in women practising Muay Thai. Turkish Journal of Kinesiology.
    DOI: https://doi.org/10.31459/turkjkin.1704368
  5. Fonseca, S. C. F., et al. (2025). Physical activity practice and negative self-rated health among university students during COVID-19. O Mundo da Saúde.
    DOI: https://doi.org/10.15343/0104-7809.202549e17082025I
  6. Pencis. (n.d.). International Research Awards on Cardiology & Cardiovascular Medicine.
    cardiology-conferences.pencis.com

Ruoxi Zhang | Cardiology | Best Researcher Award

Dr. Ruoxi Zhang | Cardiology | Best Researcher Award

Dr. Ruoxi Zhang, Harbin Medical University, China.

Dr. Ruoxi Zhang is a distinguished physician and researcher specializing in cardiovascular medicine. He earned his doctorate from Harbin Medical University and has over a decade of clinical experience at renowned institutions, including The Second Affiliated Hospital of Harbin Medical University and Suzhou Kowloon Hospital. As a guest editor for Frontiers in Medicine and Frontiers in Cardiovascular Medicine, he has contributed to advancing medical research. His extensive publications focus on artificial intelligence in cardiology, interventional techniques, and diagnostic innovations. Dr. Zhang’s dedication to medical science and patient care underscores his significant contributions to the field of cardiovascular research.

Author Profile

Suitability for Best Researcher Award

Dr. Ruoxi Zhang is a highly accomplished physician and researcher in cardiovascular medicine, with over a decade of experience in clinical practice and academic research. He holds a Doctorate in Clinical Medicine from Harbin Medical University and has served in prestigious hospitals, including The Second Affiliated Hospital of Harbin Medical University and Suzhou Kowloon Hospital at Shanghai Jiao Tong University School of Medicine.

Education:

Dr. Ruoxi Zhang has a strong academic foundation in clinical and internal medicine. He earned his Doctorate in Clinical Medicine from Harbin Medical University (2013–2016) and a Master’s degree in Internal Medicine from the same institution (2007–2010). His medical journey began with a Bachelor’s degree in Clinical Medicine from Qiqihar Medical University (2002–2007). His advanced education equipped him with extensive knowledge in diagnosing and treating complex medical conditions. Through rigorous academic training and research, Dr. Zhang has developed a deep expertise in cardiovascular medicine, laying the groundwork for his distinguished career as a physician and researcher in the medical field.

Professional Experience:

Dr. Ruoxi Zhang has over a decade of experience in clinical medicine, specializing in cardiology. He began his medical career as a physician at The Second Affiliated Hospital of Harbin Medical University, where he served for ten years, gaining expertise in patient care and advanced medical procedures. He then joined Harbin Yinghua Hospital, further refining his skills in cardiovascular treatment. Currently, he is a physician at Suzhou Kowloon Hospital, affiliated with Shanghai Jiao Tong University School of Medicine. His extensive clinical experience, combined with his research contributions, underscores his commitment to advancing cardiovascular medicine and improving patient outcomes.

Research Interests:

Dr. Ruoxi Zhang’s research interests focus on cardiovascular medicine, interventional cardiology, and advanced imaging techniques for diagnosing and treating heart diseases. He is particularly engaged in artificial intelligence applications in intracardiac echocardiography and computed tomography-derived fractional flow reserve to enhance diagnostic precision. His work explores innovative interventional strategies for patients with acute coronary syndromes, myocardial infarction, and diabetes-related cardiovascular conditions. Additionally, he investigates endothelialization processes, stent implantation techniques, and platelet aggregation in post-percutaneous coronary intervention patients. Dr. Zhang is committed to integrating novel technologies into clinical practice to improve cardiovascular outcomes and patient care.

Recognition and Impact:

Dr. Ruoxi Zhang is a distinguished physician and researcher specializing in cardiovascular medicine. As a guest editor for Frontiers in Medicine and Frontiers in Cardiovascular Medicine, he has contributed to the advancement of medical research. With numerous high-impact publications in esteemed journals, his work on artificial intelligence in echocardiography and interventional cardiology has influenced clinical practices. His research has enhanced diagnostic precision and treatment efficacy, earning recognition from the medical community. Through his dedication to innovation and patient-centered care, Dr. Zhang has established himself as a leading expert, significantly impacting the field of cardiovascular research.

Citations:

Citations – 576
h-index – 14
i10-index – 19

Conclusion:

Dr. Ruoxi Zhang’s strong academic background, extensive professional experience, editorial roles, and prolific research contributions make him a highly suitable candidate for the Best Researcher Award. His work has significantly impacted cardiovascular medicine, and his dedication to advancing medical research sets him apart as an outstanding scholar and clinician.

 Top Notable Publications

Colchicine alleviates cholesterol crystal‐induced endothelial cell pyroptosis through activating AMPK/SIRT1 pathway

Author(s): M Yang, H Lv, Q Liu, L Zhang, R Zhang, X Huang, X Wang, B Han, S Hou, …

Journal: Oxidative Medicine and Cellular Longevity

Year: 2020 📅

Atheroprotective effects of methotrexate via the inhibition of YAP/TAZ under disturbed flow

Author(s): D Liu, H Lv, Q Liu, Y Sun, S Hou, L Zhang, M Yang, B Han, G Wang, …

Journal: Journal of Translational Medicine

Year: 2019 📰

C1q/TNF‐related protein 9 inhibits the cholesterol‐induced vascular smooth muscle cell phenotype switch and cell dysfunction by activating AMP‐dependent kinase

Author(s): Q Liu, H Zhang, J Lin, R Zhang, S Chen, W Liu, M Sun, W Du, J Hou, B Yu

Journal: Journal of Cellular and Molecular Medicine

Year: 2017 🧬

C1q/Tumor necrosis factor-related protein-3 protects macrophages against LPS-induced lipid accumulation, inflammation and phenotype transition via PPARγ and TLR4-mediated pathways

Author(s): J Lin, Q Liu, H Zhang, X Huang, R Zhang, S Chen, X Wang, B Yu, J Hou

Journal: Oncotarget

Year: 2017 💡

Identification of biomarkers for unstable angina by plasma metabolomic profiling

Author(s): M Sun, X Gao, D Zhang, C Ke, Y Hou, L Fan, R Zhang, H Liu, K Li, B Yu

Journal: Molecular BioSystems

Year: 2013 🔬

Effect of clopidogrel vs ticagrelor on platelet aggregation and inflammation markers after percutaneous coronary intervention for ST-elevation myocardial infarction

Author(s): Z Jiang, R Zhang, M Sun, Q Liu, S Wang, W Wang, Q Zhao, H Zhang, …

Journal: Canadian Journal of Cardiology

Year: 2018 💓

Relationship between fragmented QRS and NT-proBNP in patients with ST elevation myocardial infarction who underwent primary percutaneous coronary intervention

Author(s): Q Zhao, R Zhang, J Hou, B Yu

Journal: Acta Cardiologica Sinica

Year: 2018 ❤️

C1q/TNF-related protein 9 attenuates atherosclerosis by inhibiting hyperglycemia-induced endothelial cell senescence through the AMPKα/KLF4 signaling pathway

Author(s): G Wang, B Han, R Zhang, Q Liu, X Wang, X Huang, D Liu, W Qiao, …

Journal: Frontiers in Pharmacology

Year: 2021 💪

Biomarkers investigation for in-hospital death in patients with Stanford type A acute aortic dissection

Author(s): R Zhang, S Chen, H Zhang, W Wang, J Xing, Y Wang, B Yu, J Hou

Journal: International Heart Journal

Year: 2016 ❤️

Effects of methotrexate in a rabbit model of in-stent neoatherosclerosis: an optical coherence tomography study

Author(s): R Zhang, S Chen, H Zhang, Q Liu, J Xing, Q Zhao, Y Wang, B Yu, J Hou

Journal: Scientific Reports

Year: 2016 🐇

Recombinant human thioredoxin-1 protects macrophages from oxidized low-density lipoprotein-induced foam cell formation and cell apoptosis

Author(s): H Zhang, Q Liu, JL Lin, Y Wang, RX Zhang, JB Hou, B Yu

Journal: Biomolecules & Therapeutics

Year: 2018 💉

Fragmented QRS complex is a prognostic marker of microvascular reperfusion and changes in LV function occur in patients with ST elevation myocardial infarction who underwent …

Author(s): R Zhang, S Chen, Q Zhao, M Sun, B Yu, J Hou

Journal: Experimental and Therapeutic Medicine

Year: 2017 🏥

Interleukin-35 promotes early endothelialization after stent implantation by regulating macrophage activation

Author(s): X Liu, R Zhang, J Hou, J Wu, M Zhang, S Fang, X Wang, X Huang, J Tian, …

Journal: Clinical Science

Year: 2019 💉

Correlation of serum uric acid levels with nonculprit plaque instability in patients with acute coronary syndromes: a 3‐vessel optical coherence tomography study

Author(s): D Zhang, R Zhang, N Wang, L Lin, B Yu

Journal: BioMed Research International

Year: 2018 🧪

Adipose tissue-derived autotaxin causes cardiomyopathy in obese mice

Author(s): Y Xu, Y Wang, J Liu, W Cao, L Li, H Du, E Zhan, R Zhang, H Liu, M Xu, …

Journal: Journal of Molecular Endocrinology

Year: 2019 🐁